Hypoglossal nerve stimulation for adults with obstructive sleep apnea
Official title: Bilateral Hypoglossal Nerve Stimulation With the XII Medical HGNS System for the Treatment of Adult Obstructive Sleep Apnea Pilot Study
Run by XII Medical · NCT07049744 · Data updated 2026-11-12
This study will test an implanted hypoglossal nerve stimulator to see if it reduces sleep apnea events and improves sleep for adults with moderate to severe OSA who cannot tolerate CPAP.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | XII Medical Industry-sponsored |
| Locations | 6 sites (Canberra, Australian Capital Territory and 5 other locations) |
| Status | Recruiting |
| Started | June 24, 2025 |
| Main results expected | December 2026 |
| Study ends | June 2029 |
| Registry record updated | July 30, 2026 |
| Trial ID | NCT07049744 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with moderate-to-severe OSA (AHI 15–50), BMI ≤32 kg/m2, central+mixed apnea index ≤25%, who have not tolerated, failed, or refused PAP are the intended candidates.
✕Probably not a fit
Patients with significant positional OSA, complete concentric soft palate collapse on DISE, central sleep apnea, hypoglossal nerve weakness, major airway anatomic abnormalities, high surgical risk, or those taking GLP-1 medications are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants will be implanted with the XII Medical hypoglossal nerve stimulation system which delivers targeted electrical pulses to the hypoglossal nerve during sleep. After device implantation, participants will use the device at home overnight and attend scheduled sleep studies to record breathing events and sleep quality. The trial enrolls adults with moderate-to-severe OSA (AHI 15–50) with BMI ≤32 and limited central/mixed apneas, and excludes those with complete concentric palatal collapse, significant positional OSA, or other contraindications to surgery. Safety and device performance will be monitored through follow-up visits and objective sleep testing over the study period.
Why it matters
Potential benefit: If successful, the device could reduce apneas and improve nighttime breathing and daytime sleepiness for patients who cannot use CPAP.
How similar studies have gone: Other hypoglossal nerve stimulation systems have shown benefit in carefully selected patients with moderate-to-severe OSA, though outcomes vary by device and patient selection.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Body Mass Index (BMI) ≤ 32 kg/m2 * AHI of 15-50 events/hour * Central + mixed apnea index ≤ 25% * Participants who have either not tolerated, have failed or refused positive airway pressure (PAP) Exclusion Criteria: * Pregnancy or breast-feeding. * Significant upper airway anatomic abnormalities * Hypoglossal nerve weakness * Central sleep apnoea condition * Significant positionally-dependent OSA. * Complete concentric patterns of soft palate collapse on DISE * Inadequately treated non-OSA sleep disorder(s). * Significant co-morbidities or prior surgeries that contra-indicate a surgical procedure or general anesthesia * Taking medications that in the opinion of the investigator may alter consciousness, the pattern of respiration, or sleep architecture * Participants on a GLP-1
Where it's running
-
Canberra ENT
Canberra, Australian Capital Territory, Australia Recruiting -
Woolcock Institute Of Medical Research
Sydney, New South Wales, Australia Recruiting -
Westmead Hospital / Chris O'Brien Lifehouse
Sydney, New South Wales, Australia Recruiting -
The Wollongong Hospital
Wollongong, New South Wales, Australia Recruiting -
Princess Alexandra Hospital
Brisbane, Queensland, Australia Recruiting -
Perth Head & Neck Surgery
Perth, Western Australia, Australia Recruiting
Study contacts
- Study coordinator: Professor Stuart MacKay FRACS
- Email: reception@illawarraent.com.au
- Phone: +61 2 4226 1055
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
F&P Mask usability in home PAP/NIV care for adults with chronic breathing conditions
This study tests how well the F&P Licorice Mask works at home for adults who already use PAP or NIV therapy.
-
Sleep apnea biomarkers and CPAP use after diagnosis
This study tests whether biomarkers from a diagnostic sleep study can predict how well adults with newly diagnosed obstructive sleep apnea will stick to CPAP therapy after about 3 months.
-
Using the PLATO Questionnaire in Oral Appliance Therapy for Obstructive Sleep Apnea
This real-world study tests whether the PLATO questionnaire can be feasibly used in dental sleep clinics for patients receiving oral appliance therapy for obstructive sleep apnea.
-
Managing COMISA: adding daridorexant to CPAP may help sleep and CPAP use
This study tests whether adding daridorexant to CPAP helps people with COMISA better stick with CPAP and feel better.
-
OSA Screening in Diverse Populations
This study tests how common obstructive sleep apnea is across community members and people with certain diseases in China, using screening questionnaires and polysomnography or portable sleep monitors.
-
Wall Squat Exercise to Help Lower Blood Pressure in Adults with Hypertension and Sleep Apnea
This study tests whether doing an isometric wall squat can lower blood pressure in adults who have high blood pressure and sleep apnea treated with CPAP.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.